Along with its other benefits, an aspirin a day may help keep head and neck cancers away, a new long-term study suggests. It wasn't so much the amount of aspirin that was taken but the length of time that people were on the drug that mattered, said study co-author Mary E. Reid, an assistant professor of oncology at Roswell Park Cancer Institute, in Buffalo, N.Y.

Dynamic Imaging announced today that its IntegradWebR PACS was ranked the No. 1 PACS by ambulatory care providers, according to the annual Ambulatory/Imaging Center PACS 2006 Report. It is the second straight year IntegradWeb PACS has achieved the honor.

Hospital practices are more to blame than how sick a person is for infections acquired by hospital patients, researchers reported on Monday, urging medical centers to do more to curb these infections.

The U.S. Centers for Disease Control and Prevention last month estimated that infections caught in U.S. hospitals kill 90,000 people annually and urged hospitals to do more to track and prevent the infections.

The dynamics of evolution are fully in play within the environment of a tumor, according to a report in the December issue of the journal Nature Reviews Cancer. The report, from researchers at The Wistar Institute, could have profound implications for understanding why current cancer therapies often fail and how radically new therapies might be devised.

Picis Inc. announced Tuesday it has completed an agreement with BT to deliver Picis' operating room management system to six hospital trusts in London. The implementation of the Picis system is scheduled to begin in December 2006.

November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San Francisco Advanced Medical Imaging, a Liberty Pacific Medical Imaging Company, to serve as the company’s newest education and training partner.

LPMI’s San Francisco Advanced Medical Imaging recently installed Toshiba’s Aquilion 64 CFX system, an advanced cardiac CT system and the cornerstone of the program.

The U.S. Food and Drug Administration has granted orphan drug designation to Repligen Corp.’s synthetic human secretin known as RG1068, to be used with magnetic resonance imaging of the pancreas. Orphan drug designation qualifies Repligen for seven years of exclusive marketing rights in the United States, if the company is first to receive marketing approval for RG1068 for MRI imaging of the pancreas.

Siemens Medical Solutions has announced plans to introduce AXIOM Artis dBA Twin, an innovative imaging system designed for universal angiography neuroradiology, at the Radiological Society of North America’s conference in Chicago next week. The AXIOM Artis dBA Twin reportedly features the largest biplane anatomical coverage available, and it is uniquely equipped with two 30x40-centimeter flat detectors.

Nuclear medicine products firm IBA Molecular displayed Empact, its new education marketing initiative for PET and PET/CT. Empact offers marketing tools specifically designed to target referring physicians and instructs users in effectively marketing PET.

Gamma Medica-Ideas debuted its fifth-generation Flex Triumph pre-clinical imaging system, which can be configured with PET, SPECT or CT subsystems, or any combination of the three.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now